[5]
Bhagirath, N.; Kennedy-Smith, J.; Lucas, M.C.; Padilla, F. 1 H-pyrazole and 4,5-disubstituted thiazole inhibitors of SYK. US Patent 9,988,378, 2018.
[8]
Zhang, G.; Ren, B.; Wang, H.; Zhao, H.; Guo, Y.; Wang, Z.; Zhou, C. 5-Amino-4-carbamoyl-pyrazole Compounds as Selective and Irreversible t790m over wt-egfr Kinase Inhibitors and Use Thereof. US Patent 2016,008,411, 2016.
[10]
Kunos, G.; Iyer, M.; Cinar, R.; Rice, K.C. Pyrazole derivatives and their use as cannabinoid receptor mediators. US Patent 10,329,259, 2019.
[11]
Lee, K.I.; Jung, Y.H.; Song, J.Y.; Jun, S.A. Pyrazole derivative as ALK5 inhibitor and uses thereof. US Patent 10,954,232, 2021.
[38]
Siu, M.; Estrada, A.; Liu, W.; Lyssikatos, J.P.; Patel, S.; Liang, G.; Chen, K. Substituted pyrazoles and uses thereof. US Patent 9,365,583, 2016.
[47]
Hui, L.; Seiji, N.; Stephanie, A.S.; Min, T.; Chunfeng, T. Novel Npyrimidin- 4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as PKC kinase inhibitors. US Patent 0,997,743, 2015.
[52]
Wang, Y.; Zhou, J.; Gao, Y.; Wang, D.; Hong, B.; Shen, X.; Wu, Y.; Li, C. Benzofuran Pyrazole Amine Protein Kinase Inhibitor. US Patent 18,001,251, 2018.
[54]
Marsilje, T.H.; Pei, W.; Chen, B.; Lu, W.; Uno, T.; Jin, Y.; Jiang, T.; Kim, S.; Li, N.; Warmuth, M.; Sarkisova, Y.; Sun, F.; Steffy, A.; Pferdekamper, A.C.; Li, A.G.; Joseph, S.B.; Kim, Y.; Liu, B.; Tuntland, T.; Cui, X.; Gray, N.S.; Steensma, R.; Wan, Y.; Jiang, J.; Chopiuk, G.; Li, J.; Gordon, W.P.; Richmond, W.; Johnson, K.; Chang, J.; Groessl, T.; He, Y.Q.; Phimister, A.; Aycinena, A.; Lee, C.C.; Bursulaya, B.; Karanewsky, D.S.; Seidel, H.M.; Harris, J.L.; Michellys, P.Y. Synthesis, structure-activity relationships, and
in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (ALK) inhibitor 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) currently in phase 1 and phase 2 clinical trials.
J. Med. Chem., 2013,
56(14), 5675-5690.
[
http://dx.doi.org/10.1021/jm400402q] [PMID:
23742252]
[56]
Short, K.M.; Estiarte-Martınez, M.D.L.A.; Kita, D.B.; Shiau, T.P. Substituted Pyrazole Compounds As Serine Protease Inhibitors. US Patent 10,532,995, 2020.
[59]
Beaton, H.; Crowe, D.M.; Edwards, H.J.; Griffiths-Haynes, N.J. Polymorphs of N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3- (methoxymethyl)-1-({4-[2-oxopyridin-1-yl)methyl]phenyl} methyl) pyrazole-4-carboxamide as kallikrein inhibitors. US Patent 11,230,537, , 2022.
[60]
Davie, R.L.; Edwards, H.J.; Evans, D.M.; Hodgson, S.T.; Pethen, S.J.; Rooker, D.P. Pyrazole Derivatives as Plasma Kallikrein Inhibitors. US Patent 11,180,484, 2021.
[64]
Findlay, A.; Turner, C.; Deodhar, M.; Foot, J.; Zhou, W.; Jarolımek, W.; Robertson, A. Haloallylamine pyrazole derivative inhibitors of Lysyl Oxidases and uses thereof. US Patent 16,490,220, 2020.
[68]
Lu, T.; Wang, Y.; Chen, Y.; Lu, Y.; Wang, Z.; Jin, Q.; Yang, T.; Lin, G.; Guo, Q.; Zhao, L. Polycyclic Substituted Pyrazole Kinase Activity Inhibitors and Use Thereof. US Patent 9,550,792, 2017.
[69]
Ford, D.J.; Horsley, H.T.; Reuberson, J.T. Fused Pyrazole Derivatives As Kinase Inhibitors. US Patent 15,762,670, 2018.
[70]
Basinger, J.; Bookser, B.; Chen, M.; Chung, D.; Gupta, V.; Hudson, A.; Kaplan, A.; Na, J.; Renick, J.; Santora, V. Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c] pyrazole and 4,5,6,7-tetrahydro- 2h-pyrazolo [4,3-c] pyridine compounds as GLYT1 inhibitors. US Patent 9,708,334, 2017.
[71]
Biagetti, M.; Capelli, A.M.; Retini, M. Pyrazole derivatives as phosphoinositide 3-kinases inhibitors. US Patent 10,189,844, 2019.
[72]
Kuntz, K.W.; Mitchell, L.H.; Shapiro, G.; Chesworth, R.; Boriack-Sjodin, P.A. PRMT1 inhibitors and uses thereof. US Patent 9,023,883, 2015.
[74]
King-Underwood, J.; Hardy, G.; Murray, P.J.; Williams, J.G.; Onions, S.T. Pyrazole P38 map kinase inhibitors. US Patent 10,000,471, 2018.
[78]
Baker-Glenn, C.; Burdick, D.J.; Chambers, M.; Chen, H.; Estrada, A.; Sweeney, Z.K.; Chan, B. Pyrazole aminopyrimidine derivatives as LRRK2 modulators. US Patent 9,212,173, 2015.
[80]
Barden, T.C.; Sheppeck, J.E.; Rennie, G.R.; Renhowe, P.A.; Perl, N.; Nakai, T.; Mermerian, A.; Lee, T.W.; Jung, J.; Jia, J.; Iyer, K.; Iyengar, R. Pyrazole derivatives as SGC stimulators. EP Patent 3,194,382, 2016.
[81]
Bagal, S.K.; Cui, J.J.; Greasley, S.E.; Lunney, E.A.; Mcalpine, I.J.; Nagata, A.; Ninkovic, S.; Omoto, K.; Skerratt, S.E.; Storer, R.I.; Warmus, J.S. Tropomyosin-related kinase inhibitors containingboth a 1H-pyrazole and a pyrimidine moiety. US Patent 15,300,440, 2017.
[84]
Huff, J.; Uesugi, M.; Kincaid, J. Di-Substituted Pyrazole Compounds For The Treatment of Diseases. US Patent 17,190,086, 2017.
[85]
Atkinson, S.J.; Demont, E.H.; Harrison, L.A.; Liwicki, G.M.; Lucas, S.C.C.; Preston, A.G.; Seal, J.; Wall, I.D.; Watson, R.J. Pyrazole Derivatives as Bromodomain Inhibitors. US Patent 10,996,961, 2021.
